Singapore Paincare Holdings Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Singapore Paincare Holdings's earnings have been declining at an average annual rate of -10.6%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 29.7% per year. Singapore Paincare Holdings's return on equity is 10.3%, and it has net margins of 7.1%.
Belangrijke informatie
-10.6%
Groei van de winst
-78.7%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 9.7% |
| Inkomstengroei | 29.7% |
| Rendement op eigen vermogen | 10.3% |
| Nettomarge | 7.1% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Singapore Paincare Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 27 | 2 | 0 | 0 |
| 31 Mar 24 | 26 | 1 | 0 | 0 |
| 31 Dec 23 | 25 | 0 | 0 | 0 |
| 30 Sep 23 | 24 | 0 | 0 | 0 |
| 30 Jun 23 | 22 | -1 | 0 | 0 |
| 31 Mar 23 | 22 | 1 | 1 | 0 |
| 31 Dec 22 | 22 | 2 | 1 | 0 |
| 30 Sep 22 | 21 | 3 | 1 | 0 |
| 30 Jun 22 | 19 | 4 | 1 | 0 |
| 31 Mar 22 | 17 | 4 | 1 | 0 |
| 31 Dec 21 | 15 | 4 | 0 | 0 |
| 30 Sep 21 | 13 | 3 | 0 | 0 |
| 30 Jun 21 | 11 | 2 | 0 | 0 |
| 31 Mar 21 | 11 | 2 | 0 | 0 |
| 31 Dec 20 | 10 | 1 | 0 | 0 |
| 30 Sep 20 | 10 | 2 | 0 | 0 |
| 30 Jun 20 | 10 | 2 | 0 | 0 |
| 31 Mar 20 | 9 | 2 | 0 | 0 |
| 31 Dec 19 | 7 | 2 | 0 | 0 |
| 30 Sep 19 | 6 | 2 | 0 | 0 |
| 30 Jun 19 | 4 | 1 | 1 | 0 |
| 30 Jun 18 | 4 | 1 | 0 | 0 |
| 30 Jun 17 | 4 | 1 | 0 | 0 |
Kwaliteitswinsten: FRQ has high quality earnings.
Groeiende winstmarge: FRQ became profitable in the past.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: FRQ's earnings have declined by 10.6% per year over the past 5 years.
Versnelling van de groei: FRQ has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Winst versus industrie: FRQ has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-35.5%).
Rendement op eigen vermogen
Hoge ROE: FRQ's Return on Equity (10.3%) is considered low.